Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2008; 133(41): 2084
DOI: 10.1055/s-0028-1091247
DOI: 10.1055/s-0028-1091247
Pro & Contra | Commentary
Humangenetik, Onkologie© Georg Thieme Verlag KG Stuttgart · New York
Genetische Testung in der Onkologie – pro
Genetic analysis in oncology – proFurther Information
Publication History
Publication Date:
01 October 2008 (online)

Schlüsselwörter
Gentest - erbliche Krebserkrankungen
Keywords
genetic testing - hereditary malignancies
Literatur
- 1
Goetz M P, Kamal A, Ames M M.
Tamoxifen pharmacogenomics: the role of
CYP2D6 as a predictor of drug response.
Clin Pharmacol Ther.
2008;
83
160-166
MissingFormLabel
- 2
Lefferts J A, Bartels C L, Tsongalis G J.
Molecular oncology: current trends in diagnostics.
Future Oncol.
2008;
4
61-70
MissingFormLabel
- 3
Peppercorn J, Carey A L.
Genotype-guided
adjuvant endocrine therapy: new tricks from an old drug?.
Expert
Rev Anticancer Ther.
2008;
8
191-194
MissingFormLabel
Prof. Dr. Ortrud Steinlein
Institut für Humangenetik, Klinikum
der Ludwig-Maximilians-Universität
Goethestr.
29
80336 München
Phone: 089/5160-4470
Fax: 089/5160-4468
Email: Ortrud.Steinlein@med.uni-muenchen.de